Schedule 13D ownership disclosure

NOVOCURE LTD ORD SHS

Security class unavailable · CUSIP: G6674U108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.2800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-464286
Form type
SC 13D
Filer
NovoCure Ltd
CIK
CIK 1645113
Filed
Feb 16, 2016
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub